Possibilities of early treatment and prophylaxis of papillomavirus infection

Isoprinosine is included to European standards of patient management with papillomavirus infection. The double antiviral drug action consists in inhibition of enzyme dihydropteroate synthetase which is involved in viral replication and suppression of viral protein production due to changes of stereochemical structure of the cell ribosome. The article presents aspects of prophylaxis of cervical cancer and modern approaches of treatment methods for papillomavirus infection.